R

RAPT Therapeutics
D

RAPT

1.24500
USD
-0.02
(-1.19%)
مغلق
حجم التداول
6,684
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
164,348,501
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABBV
    ABBV
    1.200
    (0.60%)
    202.140 USD
    AMGN
    AMGN
    5.10
    (1.71%)
    303.15 USD
    BMY
    BMY
    0.050
    (0.09%)
    55.840 USD
    BNTX
    BNTX
    2.240
    (1.90%)
    120.100 USD
    GILD
    GILD
    -0.140
    (-0.13%)
    109.920 USD
    GSK
    GSK
    -0.320
    (-0.87%)
    36.650 USD
    LLY
    LLY
    0.67
    (0.08%)
    874.04 USD
    MRNA
    MRNA
    1.785
    (5.29%)
    35.535 USD
    PFE
    PFE
    0.405
    (1.56%)
    26.305 USD
    REGN
    REGN
    4.37
    (0.63%)
    700.66 USD
    المزيد
الأخبار
المقالات

العنوان: RAPT Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cellsinto inflamed tissues.